Research
Energy balance
There is a need to end disparities in cardiovascular morbidity and mortality related to race, sex, and income inequality.
Healthcare systems should implement strategies to reduce these disparities.
StrongSupportsmedium confidence
Our aim is to enrich understanding and to inspire efforts to end disparities in cardiovascular morbidity and mortality due to race, sex and income inequality.
Why this rating
The claim is based on the stated aim of the review.
Source
Call to action: Understanding the differences in the use of SGLT-2 inhibitors and GLP-1 receptor agonists
Apurva Khedagi et al. · American Journal of Preventive Cardiology · 2023
DOI 10.1016/j.ajpc.2023.100477
reviewCited 24×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- SGLT-2 inhibitors and GLP-1 receptor agonists are effective in cardiovascular disease prevention among those with diabetes, heart failure, and chronic kidney disease.Strong
- Disparities in the use of SGLT-2 inhibitors and GLP-1 receptor agonists exist based on race, sex, and socioeconomic status.Strong
Related findings · Energy balance
- Achieving a total body weight loss of 10-15% (or >10-15 kg) through Total Diet Replacement (TDR) induces remission of Type 2 Diabetes in individuals with short-duration disease.Strong
- Bariatric surgery is superior to medical management alone for inducing significant long-term weight loss, remission of type 2 diabetes, and reduction in mortality for patients with BMI ≥ 40 or ≥ 35 with comorbidities.Strong
- Achieving type 2 diabetes remission requires significant weight loss (≥15 kg) via major caloric restriction, independent of macronutrient composition.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →